jovan-pratama
The 2026 Nobel Prize in Physiology or Medicine has been awarded jointly to three scientists whose work illuminated how the brain's individual nerve cells can be switched on or off, the Nobel Assembly announced Monday at the Karolinska Institute in Stockholm.
Karl Deisseroth, 54, Peter Hegemann, 71, and Georg Nagel, 73, were recognized for their research into light-gated ion channels and optogenetics, a technique that has transformed neuroscience by allowing researchers to control the activity of specific neurons with bursts of light. The announcement opened Nobel week, which continues with prizes in physics, chemistry, literature, peace and economic sciences over the coming days.
The three laureates are affiliated with institutions in the United States and Germany. Deisseroth works at Stanford University in California, while Hegemann is based at Humboldt University in Berlin and Nagel at the University of Wurzburg. Their combined contributions bridged disciplines, bringing together molecular biology, biophysics and neuroscience in ways that have reshaped how scientists study the brain.
Optogenetics relies on proteins known as light-gated ion channels, which occur naturally in certain microorganisms and respond to light by allowing ions to flow across cell membranes. By transplanting the genes for these proteins into neurons, researchers can make those cells sensitive to light. A brief pulse of illumination can then either excite or silence a neuron with remarkable precision, both in time and in space.
The Nobel committee praised the method's impact, writing on social media that it "is now being used in laboratories around the world to reveal the brain's mysteries." The technique has become a standard tool in neuroscience, enabling experiments that were previously impossible, from mapping the circuits that govern memory and emotion to probing the neural roots of psychiatric and neurological disorders.
The practical value of optogenetics lies in its specificity. Traditional methods of stimulating brain tissue, such as electrodes, affect broad regions and cannot easily distinguish between different types of cells. Light-based control, by contrast, can target genetically defined populations of neurons, letting scientists test hypotheses about which cells drive particular behaviors, thoughts or symptoms.
The journey toward this year's prize began with fundamental research on how single-celled organisms sense light. Hegemann and Nagel independently identified and characterized light-sensitive proteins, including channelrhodopsin, that function as ion channels. Their work established that these molecules could convert light into electrical signals, a discovery rooted in basic biology rather than any immediate medical application.
Deisseroth then helped demonstrate that these proteins could be expressed in mammalian neurons and used to control their activity. That conceptual leap turned a curiosity of microbial biology into a versatile laboratory method. Since then, optogenetics has spread across neuroscience and beyond, and the three scientists have continued to refine the underlying tools.
The prize money this year amounts to 12 million Swedish kronor, roughly $1.2 million, to be shared among the laureates. The sum is the same regardless of whether it honors a single winner, a small group or an organization, reflecting the Nobel Foundation's consistent approach to the annual awards.
Monday's medicine prize is the first in a sequence of announcements. The physics prize follows on Tuesday, chemistry on Wednesday and literature on Thursday. The peace prize will be awarded on Friday, and the Nobel Memorial Prize in Economic Sciences, established separately from the original prizes, will be announced on October 12.
Last year's medicine prize honored three scientists for research on the immune system, continuing a tradition of recognizing work that deepens understanding of human biology. This year's award shifts the focus to the nervous system and to a technology that has become a cornerstone of modern brain research.
Beyond the laboratory, optogenetics has raised hopes for new treatments, including potential therapies that could one day use light to modulate faulty brain circuits. While clinical applications remain in early stages, the method has already changed how scientists design experiments and interpret the relationship between neural activity and behavior.
For Deisseroth, Hegemann and Nagel, the recognition caps decades of work that began in different fields and converged on a shared insight: that light, harnessed through biology, can serve as a precise instrument for probing the brain. Their award underscores how fundamental discoveries in one area of science can open unexpected doors in another.
The Nobel Assembly's announcement also highlights the international character of contemporary research. With laureates at universities in both Germany and the United States, the prize reflects a long tradition of cross-border collaboration in the life sciences, where ideas and researchers move freely between institutions.
As Nobel week unfolds, the medicine award will likely draw fresh attention to optogenetics and to the broader question of how tools developed to study animal models might translate into human benefit. For now, the committee's message is clear: the ability to switch nerve cells on and off with light has become one of the most powerful ways to explore the brain's inner workings.
Comments (0)